Overview:

Glucagon is a metabolic hormone that helps to raise glucose level in the blood this is done with help of liver that rapidly converts glycogen into glucose. The glucagon is secreted by pancreas which when converted into glucose is released in blood stream. Glucagon is used in treatment of disorder such as low blood sugar.

Market Dynamics:

Increasing incidence of chronic diseases across the globe, rise in number of out-patients related to diabetes, and rapid technological advancements in pharmaceutical sector are major factors driving growth of the global glucagon market. In addition, high government spending on development of healthcare infrastructure is another important factor expected to support growth of the target market during the forecast period.

Increasing geriatric population across the globe and rising demand for non-injectable emergency glycogen are among the other factors expected to impact the growth of target market positively. In addition, increasing business expansion activities through merger and acquisitions is another factor anticipated to boost growth of the global market.

However, factors such as lack of awareness among consumers and stringent government regulation related to product approval are hampering growth of the global glucagon market to a certain extent.

Key Trends:

Major players approach towards product innovation and introduction of innovative solutions, which is a key trend observed in the target market. In 2020, Fresenius Kabi introduced a glucagon emergency medicine kit in order to treat life-threatening episodes of low blood sugar. This is expected to help the company to expand the product portfolio. In 2019, FDA approved nasal glucagon powder for the emergency treatment of severe hypoglycemia among children and adults with diabetes.

Regional Analysis:

For detailed understanding of market dynamics, the global market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major revenue share in 2018, owing to increasing number of patients suffering from diabetes and severe hypoglycemia. In addition, increasing government expenditure on healthcare sector coupled with increasing public-private partnerships and high spending on R&D activities are among other factors expected to support the growth of target market in the region.

Scope of the Report:

Detailed Segmentation:

Global Glucagon Market, By Type:

• Inject Glucagon
• Nasal Glucagon

Global Glucagon Market, By Application:

• Emergency Kits
• General Use
• Diagnostic & Motility
• Cardiogenic Shock

Key Players Covered:

Key players operating in the market includes, Хеrіѕ Рhаrmасеutісаlѕ Іnс., Ѕvаr Lіfе Ѕсіеnсе АВ, Nоvо Nоrdіѕk А/Ѕ, Еlі Lіllу & Со., Тај Рhаrmасеutісаlѕ Ltd., Frеѕеnіuѕ ЅЕ & Со. КGаА, and Тоrrеnt Рhаrmасеutісаlѕ Ltd.

Key features of the study:

Foresight Market Research provides detailed analysis on global market in our report- Global Glucagon Market by type, application, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe.